Astrix buys Daelight Solutions to expand life sciences consulting

Astrix said Tuesday it has acquired Daelight Solutions, adding Veeva Vault, clinical, regulatory and quality consulting capabilities to its pharmaceutical technology services portfolio. The deal is aimed at helping life sciences clients modernize systems, manage regulated workflows and support digital transformation.

Why it matters: - The acquisition expands Astrix’s ability to serve life sciences companies that need both technology implementation and regulated-process expertise. - Astrix gains deeper Veeva Vault capabilities, which are important for managing clinical, regulatory and quality operations in compliant environments. - The combined offering is designed to help clients modernize systems without disrupting business operations.

What happened: - Astrix announced the acquisition of Daelight Solutions on October 20, 2026. - Daelight Solutions is a clinical, regulatory and quality consulting firm serving the life sciences industry. - The deal adds Daelight’s Veeva Vault implementations and data migration expertise to Astrix’s portfolio. - Astrix is based in Red Bank, New Jersey.

The details: - Daelight brings experience in Veeva Vault implementations and validated migrations. - Daelight also adds expertise in clinical, regulatory and quality processes. - Astrix said the acquisition strengthens its ability to guide clients through complex technology initiatives while maintaining compliance. - Astrix said the deal builds on its pharmaceutical technology consulting business and broadens support across clinical, regulatory and quality operations. - The company said the combined expertise will help clients align technology investments with clinical, regulatory and quality objectives. - Daelight’s services include technology implementation, program management and business process optimization in regulated environments. - Daelight holds Veeva Vault Premier Services Partner status and Certified Migration status with Veeva. - Astrix’s broader service portfolio includes strategic planning, data strategy, AI/ML readiness and technologies, lab informatics, and modern clinical operations and eClinical platforms.

Between the lines: - The acquisition reflects a push toward consulting that connects software platforms with the business and compliance requirements behind them. - Life sciences companies are under pressure to modernize legacy systems while preserving validation and regulatory control. - Astrix is broadening from platform services into a wider advisory role across regulated operations. - Daelight’s niche expertise gives Astrix a more specialized foothold in Veeva-related work, an area that can be difficult for generalist IT firms to support well.

What's next: - Astrix said it will leverage Daelight’s domain expertise to support Veeva-related initiatives. - The combined business will focus on helping clients implement and optimize technology platforms, strengthen regulated business processes and advance digital transformation. - Astrix said it remains focused on helping life sciences clients navigate complex technology decisions and improve operational performance. - Daelight CEO Barry O’Hagan said the team expects to expand its support to more life sciences organizations as part of Astrix.

The bottom line: - Astrix is buying specialized regulatory and Veeva expertise to deepen its life sciences consulting offer and better compete for modernization projects in regulated environments. - More information: Astrix on LinkedIn